Equillium is a La Jolla biotechnology company developing treatments for autoimmune and inflammatory diseases, starting with ulcerative colitis. It last closed at $1.06 on Nov 20, down 5.36% on the day. The next earnings report for EQ is expected around Wed, Mar 24, 2027, after the close. For the quarter ended Sep 2026, EQ reported EPS of -$0.04. Over its last 8 reports the stock moved an average of 15.5% the session after earnings. Over the last 12 months EQ insiders bought $0 of stock on the open market and sold $2.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is EQ in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold EQ.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on EQStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
EQ · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 25% below its 20 day and 38% below its 50 day average. It is 96% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the Pivot S1 at $1.02, and the nearest resistance the Pivot at $1.09.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 11.8%/day
Key levels
$3.5452 week high+234.0%
$2.08200 day average+96.2%
$1.95100 day average+84.0%
$1.48Swing high (Oct 29)+39.6%
$1.4750 day average+38.7%
$1.3220 day average+24.5%
$1.14Pivot R1+7.5%
$1.09Pivot+2.8%
$1.06Last close
$1.02Pivot S1−3.8%
$0.8152 week low−23.6%
Indicators
RSI (14)
33.40
Weak, oversold below 30
Neutral
MACD
-0.10
Below its signal line
Bearish
Stochastic
8.8
Near the bottom of its range
Oversold
ADX (14)
21.0
Weak trend
Williams %R
-95.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-146.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−29.8%
Change over 10 sessions
Bearish
ATR (14)
$0.13
Typical daily range, 11.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 35.6%/day
Key levels
$3.5452 week high+234.0%
$2.08200 day average+96.2%
$1.95100 day average+84.0%
$1.48Swing high (Oct 29)+39.6%
$1.4750 day average+38.7%
$1.3220 day average+24.5%
$1.14Pivot R1+7.5%
$1.09Pivot+2.8%
$1.06Last close
$1.02Pivot S1−3.8%
$0.8152 week low−23.6%
Indicators
RSI (14)
32.42
Weak, oversold below 30
Neutral
MACD
-0.26
Below its signal line
Bearish
Stochastic
11.0
Near the bottom of its range
Oversold
ADX (14)
21.2
Weak trend
Williams %R
-98.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-110.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−49.8%
Change over 10 sessions
Bearish
ATR (14)
$0.38
Typical daily range, 35.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for EQ
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how EQ did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow EQ usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for EQHow many large options trades hit EQ, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in EQ in the last 90 days.
From SEC Form 4 filings by EQ's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EQ is in one of them and how their past EQ trades turned out.
Equillium is a biotechnology company in La Jolla, California, that develops treatments for severe autoimmune and inflammatory diseases. Its lead candidate, EQ504, works on the aryl hydrocarbon receptor and is being developed first for ulcerative colitis and other gut diseases. The company also has an oral candidate, EQ302, that blocks two inflammatory signaling proteins and is aimed at celiac disease. Both candidates are still in development and not yet sold, with patients who have gut and immune disorders as the intended users.